I Still Like the Stock, but This Definitely Isn't Warren Buffett's Berkshire Hathaway Anymore

Berkshire Hathaway’s Q1 under new CEO Greg Abel showed a tighter portfolio focus, with 16 small positions sold, exits from underperformers like Pool, UnitedHealth, Domino’s, and most of Constellation Brands, and new stakes in Delta Air Lines and Macy’s. The company’s cash hoard reached a record $397 billion, suggesting patience on larger equity purchases and a possible shift toward more wholly owned businesses. The article frames Abel’s approach as more selective and willing to take calculated risks than Buffett’s more traditional style.

Analysis

This reads less like a style tweak and more like a portfolio architecture change. A manager willing to prune sub-1% positions and realize losses quickly is implicitly raising the hurdle rate for capital allocation, which should improve Berkshire’s future opportunity cost discipline but also reduce the “diversified buy-the-whole-holdco” appeal that once justified passive ownership. The near-term market consequence is a quieter tracker effect: fewer micro-signals from small buys/sells, more attention on any large deployment of cash or wholly owned acquisitions.

The most important second-order effect is that Abel appears more willing than Buffett to use the public portfolio as a scouting ground for mispriced optionality rather than durable compounders. That shifts the risk profile toward names with asymmetric restructuring outcomes, where the upside is driven by balance-sheet repair, asset monetization, or multiple re-rating rather than organic growth. Those are harder to underwrite, more timing-sensitive, and more likely to generate false positives if the operating turnaround takes longer than one to two years.

For the listed beneficiaries, the signal is mixed. High-quality “too small to matter” franchises like V, MA, AON, CHTR, and AMZN lose a marquee incremental buyer, while deep-value/asset-backed names like M and potentially GS gain implied validation that Berkshire is hunting for hidden optionality. On the short side, UNH, STZ, DPZ, and POOL look vulnerable to a broader de-rating if investors conclude Berkshire exited not because of valuation but because the underlying thesis broke; that can pressure peer multiples across managed care, packaged beverages, casual dining, and housing-linked discretionary demand.

The real contrarian point is that Berkshire may be exiting the public market at exactly the time dispersion is widening. If the AI-led index concentration unwinds, cash-rich conglomerates with patience should actually get a better hunting ground over the next 6-18 months. The question is not whether cash is a problem, but whether Abel converts it into idiosyncratic upside fast enough before the market leadership changes and the opportunity set improves.

Key Decisions for Investors

• Short UNH vs long XLV for 3-6 months: the exit signal suggests idiosyncratic balance-sheet/operating risk is being re-priced; use the ETF hedge to isolate company-specific downside, targeting 1.5-2.0x upside to downside if managed-care sentiment deteriorates further.
• Initiate a tactical short basket in STZ/DPZ/POOL for 1-3 months: these names are most exposed to ‘thesis broken’ reads, and Berkshire’s abandonment can extend multiple compression another 10-15% even if fundamentals do not immediately worsen.
• Long GS on pullbacks for 6-12 months: if Berkshire is explicitly favoring optionality and event-driven upside, GS remains the cleanest liquid expression of that mindset with operating leverage to capital-markets re-acceleration and restructuring flow.
• Sell call spreads on V and MA into strength over the next 1-2 quarters: reduced elite-holder sponsorship lowers the chance of a valuation reset catalyst, but also removes a steady source of long-only marginal demand; upside likely capped absent a renewed growth re-acceleration.
• Hold BRK.B as a defensive cash-compounding vehicle, but size it lower than before on a relative basis: the equity portfolio is becoming more selective and less benchmark-like, so upside from ‘Buffett premium’ is likely to be smaller than the market assumes until Abel proves repeatable capital deployment.